发明名称 Metalloenzyme inhibitor compounds
摘要 The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
申请公布号 US9220265(B2) 申请公布日期 2015.12.29
申请号 US201414297065 申请日期 2014.06.05
申请人 Viamet Pharmaceuticals, Inc. 发明人 Hoekstra William J.;Yates Christopher M.;Schotzinger Robert J.;Loso Michael R.;Buchan Zachary A.;Sullenberger Michael T.;Gustafson Gary D.
分类号 A01N43/78;A01N43/713;C07D401/14;C07D401/06;C07D409/14;C07D417/14;A01N25/00;A01N43/647;A01N43/653 主分类号 A01N43/78
代理机构 Wolf, Greenfield & Sacks, P.C. 代理人 Wolf, Greenfield & Sacks, P.C.
主权项 1. A method of treating or preventing a metalloenzyme-mediated disease or disorder in or on a plant comprising contacting a composition comprising a compound of Formula I with the plant or seeds; wherein MBG is optionally substituted tetrazolyl, optionally substituted triazolyl, optionally substituted oxazolyl, optionally substituted pyrimidinyl, optionally substituted thiazolyl, or optionally substituted pyrazolyl; R1 is H, halo, alkyl or haloalkyl; R2 is H, halo, alkyl or haloalkyl; R3 is independently H, alkyl, nitro, cyano, haloalkyl, alkoxy, halo, haloalkoxy, alkenyl, haloalkenyl, cycloalkyl, halocycloalkyl, alkynyl, haloalkynyl, thioalkyl, SF3, SF6, SCN, SO2R6, —C(O)-alkyl, —C(O)OH, —C(O)O-alkyl, C(O)H, CH═N—O-alkyl, —CH═N—O-arylalkyl; R4 is aryl, heteroaryl or cycloalkyl optionally substituted with 0, 1, 2 or 3 independent R3; R5 is alkyl, haloalkyl, cycloalkyl, C2-C8 alkenyl, C2-C8 alkynyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl, each optionally substituted with 0, 1, 2 or 3 independent R3; R6 is alkyl, aryl, substituted aryl, heteroaryl or substituted heteroaryl; R7 is H, alkyl, —Si(R8)3, —P(O)(OH)2, —CH2—O—P(O)(OH)2, or —C(O)-alkyl optionally substituted with amino; R8 is independently alkyl or aryl; R9 is independently H, alkyl, halo, or haloalkyl; and X is O or S.
地址 Durham NC US